221 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:08am
, indicators on profit, R&D targets. Based on factors including the achievement of company performance goals, a performance linked coefficient which varies … and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:04am
and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:03am
and includes initiatives to optimize its workforce—simplifying some division structures—and rigorously prioritize its R&D pipeline, while investing in DD&T … options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:02am
, termination of some of partnered R&D programs coupled with increased R&D expense accruals, and higher other operating expenses. Core Operating Profit increased … impacted by generic entrants for high-margin products and strategic investments in R&D and our data, digital and technology capabilities to ensure our
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
(1) Business Performance
(i) Business Overview
Takeda is a global, values-based, R&D-driven biopharmaceutical company with a diverse portfolio … areas: Gastroenterology (“GI”), Rare Diseases, Plasma-Derived Therapies (“PDT”)*1, Oncology, Vaccines*2 and Neuroscience. Our R&D efforts are focused
6-K
EX-99.1
9hl07qwt7hkj8 n3
9 May 24
Current report (foreign)
6:01am
6-K
EX-99.1
jjjgn531pdv
19 Apr 24
Current report (foreign)
6:12am
6-K
dgjcllv8n lf
15 Apr 24
Current report (foreign)
6:02am
6-K
irqlh9r
27 Mar 24
Current report (foreign)
6:34am
6-K
agpyrkf4 64ikcn
9 Feb 24
Current report (foreign)
6:03am
6-K
kin2jpsc99kg
2 Feb 24
Current report (foreign)
6:16am
6-K
n6jlu95m44ftbrkxxri
1 Feb 24
Current report (foreign)
6:18am
6-K
fmh5s9wmoq
1 Feb 24
Current report (foreign)
6:06am
6-K
EX-99.1
h6nkx81ysq4vjk
1 Feb 24
Current report (foreign)
6:06am
6-K
ojq6yrn
16 Jan 24
Current report (foreign)
6:01am
6-K
EX-99.1
2bz8ssedk345lj4
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
o91ed lgxelaqgt0n
30 Nov 23
Current report (foreign)
6:01am
6-K
u30bmh
13 Nov 23
Current report (foreign)
6:05am
6-K
hmxboxb9pevre
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
hylah
30 Oct 23
Current report (foreign)
6:02am